-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Exhibits at Fi Europe in France, Continuously Expanding Its Market Reach
Category:
发布时间：2025-12-03
【概要描述】
On December 2, local time, the highly influential global event in the food ingredients and health sectors—the 2025 Fi Europe European Food Ingredients Exhibition—grandly opened at the Paris Expo Porte de Versailles. As a proactive force driving the internationalization of China’s pharmaceutical and health industry, the foreign trade delegation from Shijiazhuang Sihua Pharmaceutical Group once again traveled to Europe to showcase the company’s innovative development momentum to global business partners, thereby actively igniting a new engine for accelerating market penetration in Europe and expanding diversified business collaborations in the coming year.
On December 2, local time, Fi Europe 2025—the globally influential premier event in the food ingredients and health sectors—grandly opened at the Paris Expo Porte de Versailles. As a dynamic force driving the international expansion of China’s pharmaceutical and health industry, the foreign trade delegation from Shijiazhuang Sihua Pharmaceutical Group once again traveled to Europe to showcase the company’s innovative momentum to global business partners, thereby actively igniting a new engine for accelerating market development in Europe and broadening diversified business collaborations in the year ahead.
This year’s Fi Europe exhibition brought together more than 1,500 exhibitors from around the globe and attracted over 25,000 industry leaders and professional visitors. The Group’s key displays—food additives and specialty APIs—drew numerous European and international buyers and partners who stopped by to engage in discussions. The booth was bustling with visitors, fostering a lively exchange that vividly underscored the international market’s strong recognition of and ongoing interest in the Group’s products.
In recent years, the Group’s caffeine raw materials have earned widespread recognition in international markets thanks to their high purity and traceability. As one of the world’s leading caffeine suppliers, the Group has continuously optimized its production processes and implemented end-to-end green management. It obtained international carbon footprint certification in 2024 and the EU CEP certificate in 2025, with its products now exported to more than 60 countries and regions worldwide, steadily enhancing its global competitiveness and brand influence.
“Going global” to engage in worldwide competition and cooperation is a key strategic pillar underpinning the Group’s commitment to integrated API–formulation development. In recent years, with a focus on fostering smooth domestic–international dual circulation, the Group has not only intensified R&D on new products but also obtained multiple international certifications, thereby continuously elevating product quality and technological standards. Moreover, by leveraging major international trade fairs and other platforms, the Group has gained deep insights into global market trends and customer needs, worked diligently to establish international marketing channels and networks, and steadily expanded its network of foreign-trade partnerships.
“Participating in Fi Europe this time is not only a vital platform for showcasing our new products and latest developments, but also a key venue for strengthening existing customer relationships, identifying potential partners, and gaining insights into cutting-edge industry trends,” said the Group’s head of API international trade. In recent years, through the consistent implementation of the “going global” strategy, the Group has successfully introduced API products—led by coffee beans—into the European market, thereby establishing a strong reputation and achieving steady growth in export revenues.
“Europe is one of the key regions for accelerating our international expansion. By participating in trade shows and other initiatives, we showcase our high-quality products and our commitment to integrating into global value chains, thereby deepening customer awareness and trust and laying the foundation for expanding partnerships and increasing our market share. Moving forward, the Group will closely align with global market trends, continuously optimize our products and services, and advance our internationalization journey at a more steady pace,” said the Group’s head.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091